CEC15th | ESVS@CEC International Specialty（Online 11-03 Fri 13:00-15:00）

☆ CEC China Vascular Forum ☆

CEC China Vascular Forum is the largest vascular surgery conference in China and a top event with international influence. Since its establishment in 2008, CEC has been committed to strengthening basic treatment, standardizing clinical operation, serving frontline doctors, tracking major researches, comprehensively displaying the latest advances in the field of vascular disease diagnosis and treatment both at home and abroad, and promoting the progress and innovation of clinical diagnosis and treatment and scientific research of China's vascular diseases with the latest technology and the broadest disciplinary cooperation, enjoying a high reputation both domestically and internationally.

☆ European Society for Vascular Surgery（ESVS）☆

Founded in London on May 6, 1987, and now staffed by more than 2,800 medical specialists involved in the care and treatment of vascular disease in countries across Europe and elsewhere, the ESVS is committed to providing the best possible care for people with vascular disease by promoting scientific advocacy and research into vascular disease through education, research, the organization of scientific meetings, the development of guidelines for dissemination and the publication of journals. Each year, the ESVS Annual Meeting attracts more than 1,400 professionals.

专家介绍

Prof. Zhong Chen

Capital Medical University

Beijing Anzhen Hospital Vascular Surgery

Center Director, Chief Physician

Second Class Professor, Doctoral Supervisor

• • President of the Vascular Surgery Physicians Branch of the Chinese Medical Doctor's Association
  • Chairman of Vascular Surgery Group, Chinese Medical Association Surgery Branch
  • Founding Chairman, Vascular Surgery Section, Cross-Strait Medical and Health Exchange Association
  • Chairman of the Vascular Surgery Section of the Beijing Medical Association
  • Honorary Chairman of the Department of Vascular Surgery, Capital Medical University
  • He has presided over and participated in more than a dozen research projects, including the National 863 Project, the National Natural Science Foundation of China, the Natural Science Foundation of Beijing Municipality, and the research and development projects of the Science and Technology Program of Beijing Municipal Science and Technology Commission.
  • As the first author or responsible author, he has published more than 130 academic papers, including 15 SCI articles, 5 provincial and municipal scientific research achievement awards, and many books as the editor-in-chief, translator and compiler.
  • He has been awarded the “Outstanding Contribution Award for Stroke Screening and Prevention” by the Health Planning Commission, the “Sincere Physician” and the “Famous Physician of the Nation - Excellence Award” in 2018, and the “Glory Award” in 2020. In 2018, he was honored with the “Sincere Physician” and “Famous Physician of the Nation - Excellence in Construction Award”; in 2020, he was honored with the “Golden Lancet Award”; and in 2021, he was honored with the “Elite Model Award of Stroke Prevention and Treatment Project of the Commission on Health”.

   

•  

• • Chairman, Vascular Medicine Specialized Committee, Chinese Society of Research Hospitals

  • Vice Chairman of Vascular Surgery Branch, Chinese Medical Doctors' Association

  • Member of Vascular Surgery Group, Chinese Medical Association Surgical Branch

  • Consultation expert of the Central Healthcare Commission

  • 《Annalsof Vascular Surgery: Brief reports and Innovations》和《Frontiers in Surgery》associate editor

  • 《Journal of Endovascular Therapy》、《Annals of Vascular Surgery》、《Chinese Journal of Surgery》Editorial board member of more than 10 journals

  • Published more than 280 papers, including more than 120 SCI, the highest impact factor of 35.9 points; published 4 monographs

  • Undertake more than 10 national and provincial-level projects

  • He was awarded the first prize of National Scientific and Technological Achievements, the first prize of Beijing Science and Technology, the first prize of All-Army Medical Achievements, the second prize of All-Army Medical Achievements, and so on.

  • Leading the development of vascular surgery technology for nearly 20 years with cutting-edge innovative treatment concepts

  • As the only team in China to do live surgery for 12 consecutive years for the LINC Congress in Germany; 3 consecutive years for the C3 Congress in the U.S.; and live surgery for the CICE Congress in South America.

  • Over the years, he has invented and completed a series of innovative procedures, including the international first “WeFlow-Arch” series of innovative product development for the treatment of aortic arch aneurysms, the international first “G-Branch” for the treatment of thoracoabdominal aortic aneurysms, the international first “WeFlow-JAAA” for the treatment of proximal renal abdominal aortic aneurysms, the international first “”G-iliac” endoluminal reconstruction of internal iliac artery, etc. “WeFlow-JAAA” for the treatment of near-renal abdominal aortic aneurysm, and ‘G-iliac’ for the endoluminal reconstruction of the internal iliac artery, the first of its kind in the world. He also put forward theoretical innovations such as the “typing of the destroyed form of visceral arteries in aortic coarctation”, “typing of the form of blood supply after the destruction of visceral arteries”, and “301 typing” for predicting the regression of aortic coarctation after endoluminal repair surgery. “Theoretical innovations such as

  • He has been awarded the VEITH International Innovation Award for two consecutive years, the Chinese Physician Award, and the People's Good Doctor Award for “Excellence in Construction” and “Outstanding Style”. He is an internationally recognized expert in vascular surgery.

•  

Prof. Fu Weiguo

Deputy Director, National Clinical Medical Research Center for Radiation and Therapy

Director of Vascular Surgery, Zhongshan Hospital, Fudan University

Director of Fudan University Vascular Surgery Institute

Director of the Institute of Vascular Surgery

Second Class Professor, Doctoral Supervisor

• The first vascular surgeon in China
• Young and middle-aged experts with outstanding contributions from the Ministry of Health
• Shanghai Craftsman, Shanghai Leading Talent, Shanghai Outstanding Discipline Leader, Selected by Shanghai Health System Hundred Talent Plan
• Vice Chairman of Vascular Surgery Group of Chinese Medical Association Surgery Branch.
• Vice Chairman of Vascular Surgery Division, Chinese Medical Association (CMA)
• Chairman of Vascular Surgery Branch of Cross-Strait Medical and Health Exchange Association.
• Chairman of Thoracic Aortic Group, Vascular Surgery Physicians Branch, Chinese Medical Doctors' Association
• Chairman of Shanghai Physicians Association Vascular Surgery Physicians Branch
• Former Chairman of Shanghai Municipal Medical Association Vascular Surgery Specialist Branch
• Vice Chairman of Endoluminal Angiology Specialized Committee of Chinese Physicians Association (CPA)
• Chairman, Aortic Clamping Expert Committee, Endovascular Specialty Committee, Chinese Physicians Association
• Vice Chairman, Vascular Surgery Committee, Gerontology Branch, Chinese Medical Doctors' Association (CMA)
• Vice Chairman, Vascular Surgery Committee, China Association for the Promotion of International Exchange in Healthcare (CAPIEH)
•  

• Author or co-author of 55 peer-reviewed scientific publications, with 59 current PubMed entries
• Senior Vascular Surgeon, Sahlgrenska University Hospital, Sweden
• Interested in evidence-based diagnosis, treatment and overall management of peripheral arterial disease, with several clinical trials in this area.
• Chairman of the National Quality Register for Vascular Surgery (Swedvasc)
• First ever registry-based randomized clinical trial in vascular surgery in Sweden
• Member of the European Society for Vascular Surgery (ESVS) and member of the editorial board of the European Journal of Vascular and Endovascular Surgery
• Chairman of the writing committee for the upcoming PAD guidelines (focusing on asymptomatic PAD and intermittent claudication) currently being developed by ESVS

• 【field of research】

  Vascular Surgery, Endovascular Surgery, Aneurysms, Angiography, Vascular Bypass and Kidney Transplantation

Prof. Xiangchen Dai

General Hospital of Tianjin Medical University

Vice President

Deputy Director of General Surgery Center

Director of Department of General Surgery

Director of Vascular Surgery

• Member of Vascular Surgery Group of Chinese Medical Association Surgery Branch
• Member of Vascular Surgery Group, Surgery Branch, Chinese Medical Association, China
• Chairman of Vascular Surgery Group of Tianjin Medical Association Surgery Branch
• Vice Chairman of Tianjin Physicians Association Interventionalists Branch
• Vice Chairman of Vascular Surgery Branch, China Association for the Promotion of Medical Science (CAPMS)
• Vice Chairman of Vascular Surgery Specialized Committee of China Association for the Promotion of Science and Technology
• Vice Chairman, Specialized Committee of Integrative Vascular and Endovascular Surgery, Integrative Physicians Branch, Chinese Physicians Association (CPA)
• Vice Chairman of the Venous Group of the Vascular Surgery Branch of the Sea Medical Association, etc.
• Member of the Editorial Board of the Journal of Vascular and Endovascular Surgery and Deputy Director of the Academic Committee,
• Editorial board member of Chinese Journal of Vascular Surgery, Chinese Journal of Vascular Surgery, etc.
• Mastering the diagnosis and interventional treatment of aortic, visceral, subclavian and limb arteries, vena cava stenosis (occlusion) and other vascular diseases, as well as interventional treatment of various tumor diseases.

• Standing Committee Member and Director General, Vascular Surgery Physicians Branch, China Medical Doctors Association
• Vice Chairman, Vascular Surgery Committee, China Medical Education Association (CMEA)
• Vice Chairman of Carotid Artery Group, Vascular Surgery Branch, China Association for the Promotion of International Exchange in Healthcare (CAPIEH).
• National Member of Vascular Surgery Specialized Committee of National Cardiovascular Disease Expert Committee
• Vice Chairman, International Union of Angioloy Chinese Chapter (IUA-C), Thoracic Aortic Disease Specialist Committee
• International member of Society for Vascular Surgery International (SVS).
• Editorial board member of Chinese Journal of Vascular Surgery, Chinese Journal of Surgery, etc.

• Chairman, Vascular Surgery Committee, China Medical Education Association

• Member of Vascular Surgery Group of Chinese Medical Association Surgery Branch
• Member of the Standing Committee of Vascular Surgery Branch, Chinese Physicians Association
• Vice Chairman of the Vascular Surgery Committee of China Association for the Promotion of International Exchange in Health Care and Chairman of the Aortoiliac Artery Group.
• Vice Chairman of Health Medicine Branch of National Health Industry Enterprise Management Association (NHIEMA)
• Vice Chairman of Beijing Physicians Association Vascular Surgery Specialist Branch
• Member of Rheumatic Disease Specialist Committee of Cross-Strait Medical and Health Exchange Society
• Member of the Standing Committee of Vascular Surgery Specialty Committee of National Committee of Cardiovascular Disease Experts, and other positions in more than 20 academic organizations.
• Editorial board member or reviewer of more than ten journals, including Chinese Journal of Vascular Surgery, Chinese Medical Journal, Chinese Journal of Surgery, Chinese Journal of General Surgery, Chinese Medical Jurnal and so on.
• He has accumulated rich clinical experience in minimally invasive intervention, open surgery and drug treatment of multiple aortitis, aortic coarctation, thoracic and abdominal aortic aneurysm, peripheral artery aneurysm, visceral artery aneurysm, carotid artery stenosis, subclavian artery stenosis, renal artery stenosis, Bugart's syndrome, arteriosclerotic occlusive disease of the lower limbs, and deep vein thrombosis, etc., and is in a leading position in China in the surgical treatment of aortitis, in particular. Leading position in surgical treatment of aortitis
• He has undertaken more than ten national/provincial projects.
• He has published more than 90 papers as first author or corresponding author, including more than 30 SCI papers.

• Deputy Director, Department of Vascular Surgery, Capital Medical University
• Vice President and Secretary General, International Union of Angiology (IUA) China Chapter
• Chairman of the Lower Extremity Artery Expert Committee of the International Union of Angiology (IUA) China Chapter
• Vice Chairman of Limb Preservation Group, Chinese Medical Association, Tissue Repair and Regeneration Branch.
• Member and Secretary General of Stem Cell Engineering Group, Medical Engineering Branch, Chinese Medical Association (CMA)
• Standing Committee Member and Secretary General of Diabetic Foot Disease Branch, China Association for the Promotion of International Exchange in Healthcare (CAPIEH)
• Standing Committee Member and Deputy Secretary General of Peripheral Vascular Disease Specialized Committee of Chinese Microcirculation Society
• Vice Chairman of Thromboembolic Vasculitis Specialized Committee of Peripheral Vascular Disease Specialized Committee of Chinese Society of Integrative Medicine and Western Medicine.
• Vice Chairman, Specialized Committee on Aortoiliac Artery Disease, Endoluminal Vascular Physicians Branch, Chinese Medical Doctors' Association.
• Vice Chairman, Carotid Artery Group, Vascular Surgery Branch, Beijing Medical Association
• Executive Director and Director General of Beijing Physicians Association Interventional Specialists Branch
• Vice Chairman of Vascular Surgery Specialized Committee of Beijing Perioperative Medicine Research Society
• He has long been engaged in the clinical diagnosis and treatment of vascular surgical diseases and scientific research, especially specializing in the minimally invasive interventional and surgical treatment of ischemic diabetic foot, carotid artery stenosis, lower limb atherosclerotic occlusive disease, and aortic diseases.
• She has presided over and participated in more than 10 national, provincial, ministerial and bureau-level projects. She has presided over and participated in a large number of clinical researches on new drugs and devices. He has been awarded 1 first prize of China Medical Science and Technology Progress Award, 2 first prizes of China Medical Science and Technology Progress Award, and 1 second prize of Beijing Science and Technology Progress Award. 2 patents
• Published more than 60 papers in SCI and core journals. Editor-in-chief and associate editor of 5 monographs and co-editor of 8 monographs.

• 2009 Studied at Cardiovascular Center, Leipzig University, Germany
• Vice Chairman of Vascular Trauma Group, Vascular Surgery Branch, Chinese Physicians Association, China
• Standing Committee Member of Vascular Surgery Branch, Beijing Physicians Association
• Vice Chairman of Youth Committee
• Secretary General of Vascular Branch of China Medical Device Industry Association
• Editorial board member of Chinese Journal of Surgery and Chinese Edition of Annals of Vascular Surgery.
• In 2012, he was awarded the first prize of “Chinese Young Scholars Award in Surgery” by the Surgical Association of Chinese Medical Association.
• Specialized in modern minimally invasive treatment of vascular diseases.

• Vice Chairman, China Association for the Advancement of Science
• Vice Chairman of the Youth Group of the Diabetic Foot Branch of the China Association for the Promotion of International Exchange in Health Care (CAPEIC)
• Standing member of the Hemodialysis Access Group of the Vascular Surgery Branch of the China Society for the Promotion of International Exchange in Health Care (CSPIEHC)
• Vice Chairman of the Middle-aged and Young People's Committee of Peripheral Vascular Disease Specialized Committee of Chinese Microcirculation Society
• Member of Lower Extremity Arterial Disease Committee, Endovascular Specialized Committee, Chinese Physicians' Association
• Member of Vascular Surgery Branch, Chinese Physicians Association
• Member of Shanghai Medical Association Vascular Surgery Specialized Sub-Committee
• Editorial Board Member of Chinese Journal of Vascular Surgery, Chinese Journal of Vascular Surgery (Electronic Edition), Corresponding Editorial Board Member of Clinical Misdiagnosis and Mistreatment.
• He specializes in interventional and surgical treatment of arterial and venous vessels, arterial occlusion, lower limb arterial occlusion, acute and chronic deep vein thrombosis, diabetic foot, abdominal aortic aneurysm, benign superior vena cava obstruction, Bugart's syndrome.